Lockheed Martin Corp (LMT) · Oct 22, 2026 · Earnings
Beat — Diluted EPS $7.97 vs ~$7.51 consensus; sales $20.71B vs ~$20.48B
Lockheed Martin’s Q3 earnings beat consensus and the company raised its 2026 sales, EPS and free-cash-flow outlook—but F-35 funding remains unresolved.
Lockheed Martin is riding a defense-spending and weapons-production ramp, with missile-defense programs such as PAC-3 and THAAD becoming an increasingly important growth engine while F-35 remains a major volume driver. Its prior-quarter outlook had already pointed to stronger demand and higher 2026 expectations, so this is an execution update rather than a completely new demand story.
The quarter beat the published bar. Diluted EPS was $7.97 versus roughly $7.51 consensus, while sales were $20.71 billion versus approximately $20.48 billion expected. That is a clear earnings beat, though the revenue outperformance was modest. Sales rose 11% year over year and net earnings rose 14%.
| Measure | Q3 2026 | Q3 2025 / expectation | Change |
|---|---|---|---|
| Sales | $20.711B | $18.609B; ~$20.48B consensus | +11% YoY; above consensus |
| Diluted EPS | $7.97 | $6.95; ~$7.51 consensus | +15% YoY; above consensus |
| Business segment operating profit | $2.229B | $2.029B | +10% YoY |
| Cash from operations | $3.438B | $3.728B | -8% YoY |
| Free cash flow | $2.999B | $3.347B | -10% YoY |
| Backlog | $291.984B | $193.622B at Dec. 31, 2025 | +51% since year-end |
The real upgrade is in the full-year outlook. Lockheed raised its sales range to roughly $80.0 billion-$82.0 billion from $79.75 billion-$81.75 billion, EPS to $30.35-$30.75 from $29.95-$30.65, and free cash flow to $7.8 billion-$8.0 billion from $7.0 billion-$7.2 billion. The cash-flow increase is especially meaningful because quarterly cash generation fell year over year, making the full-year upgrade dependent on a stronger fourth quarter and working-capital conversion. 〔0〕
Missiles are carrying the growth narrative. Missiles and Fire Control sales jumped 24%, driven by PAC-3, THAAD, GMLRS and PrSM production ramps, while its operating profit also rose 24% (Segment results — Missiles and Fire Control). Rotary and Mission Systems delivered only 3% sales growth, and Space profit was flat in the quarter, so the acceleration is not equally broad across the portfolio. The record $292 billion backlog supports longer-term visibility, but much of that backlog still has to be converted through production capacity and government funding.
The unresolved F-35 contract is the main qualification. Aeronautics benefited from $710 million of higher F-35 sales, but Lockheed says costs on the Lot 20 advance-acquisition contract began exceeding current authorization and funding during the quarter. The company remains in negotiations with the U.S. government, and explicitly warns that a failure to secure additional authorization and funding would hurt future results, cash flow and financial condition. 〔1〕 〔2〕
Bottom line: This is better than expected: Lockheed beat Q3 estimates and raised its outlook again, with missile production and backlog validating the growth story. The positive read is tempered by weaker quarterly cash flow and a material F-35 funding issue that now matters more than the routine earnings beat.
F-35 Lot 20 contract authorization and funding
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!